Pierachille Santus Selected Research

Pierachille Santus Research Topics

Disease

41	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 01/2004
23	Asthma (Bronchial Asthma) 12/2022 - 01/2002
15	COVID-19 02/2022 - 01/2020
11	Inflammation (Inflammations) 04/2022 - 01/2002
7	Pneumonia (Pneumonitis) 01/2022 - 10/2012
7	Dyspnea (Shortness of Breath) 01/2020 - 12/2009
6	Respiratory Insufficiency (Respiratory Failure) 01/2022 - 01/2020
5	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2016 - 07/2012
3	Lung Diseases (Lung Disease) 12/2020 - 07/2012
2	Psoriasis (Pustulosis Palmaris et Plantaris) 10/2020 - 01/2018
2	Arthritis (Polyarthritis) 10/2020 - 01/2016
2	Hypoxia (Hypoxemia) 04/2020 - 08/2007
2	Cough 01/2017 - 12/2014
1	Human Influenza (Influenza) 12/2021
1	Virus Diseases (Viral Diseases) 12/2021
1	Disease Progression 12/2021
1	Cardiac Arrhythmias (Arrythmia) 11/2021
1	Facial Dermatoses 04/2021
1	Contact Dermatitis (Eczema, Contact) 04/2021
1	Ageusia (Hypogeusia) 01/2021
1	Insulin Resistance 01/2021
1	Skin Diseases (Skin Disease) 01/2021
1	Thrombosis (Thrombus) 01/2021
1	Anosmia 01/2021
1	Psoriatic Arthritis 10/2020
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 04/2020
1	Airway Obstruction (Choking) 01/2020
1	Thrombophilia 01/2020
1	Body Weight (Weight, Body) 01/2020
1	Obstructive Sleep Apnea 12/2019
1	malar rash 09/2019
1	Systemic Scleroderma (Systemic Sclerosis) 07/2019
1	Autoimmune Diseases (Autoimmune Disease) 07/2019
1	Interstitial Lung Diseases (Interstitial Lung Disease) 07/2019

Drug/Important Bio-Agent (IBA)

19	Bronchodilator Agents (Bronchodilators)IBA 01/2022 - 01/2004
14	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2021 - 01/2017
11	Tiotropium Bromide (Spiriva)FDA Link 11/2017 - 01/2004
10	Pharmaceutical PreparationsIBA 01/2021 - 06/2009
10	Formoterol Fumarate (Oxis)FDA Link 01/2018 - 01/2004
9	Muscarinic AntagonistsIBA 01/2022 - 01/2016
6	GoldIBA 01/2022 - 11/2017
6	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2020 - 01/2018
5	Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric 01/2019 - 12/2015
4	Biological ProductsIBA 04/2022 - 01/2019
4	Biomarkers (Surrogate Marker)IBA 09/2020 - 01/2018
4	Carbon MonoxideIBA 07/2019 - 02/2012
4	indacaterolIBA 01/2019 - 06/2014
4	Cholinergic Antagonists (Anticholinergics)IBA 01/2017 - 05/2009
3	Omalizumab (Xolair)FDA Link 01/2020 - 01/2018
3	Salmeterol Xinafoate (Serevent)FDA Link 02/2012 - 01/2007
2	mepolizumabIBA 04/2022 - 01/2020
2	Immunoglobulin E (IgE)IBA 04/2022 - 01/2021
2	benralizumabIBA 04/2022 - 01/2020
2	CytokinesIBA 01/2022 - 01/2021
2	Antiviral Agents (Antivirals)IBA 12/2021 - 01/2021
2	fibrin fragment D (D-dimer)IBA 01/2021 - 01/2020
2	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 12/2018
2	SteroidsIBA 09/2020 - 01/2020
2	Oxygen (Dioxygen)IBA 01/2019 - 08/2007
2	AntioxidantsIBA 12/2014 - 04/2005
2	LeukotrienesIBA 04/2005 - 01/2002
2	Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA 04/2005 - 01/2002
1	Drug CombinationsIBA 12/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 12/2021
1	Interleukin-8 (Interleukin 8)IBA 12/2021
1	ChemokinesIBA 12/2021
1	Immunologic Factors (Immunomodulators)IBA 12/2021
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 12/2021
1	Monoclonal AntibodiesIBA 12/2021
1	AnticoagulantsIBA 12/2021
1	3- (2- (4- azidobenzamidino)ethyl)- 5- hydroxyindole (SABA)IBA 11/2021
1	Irritants (Vesicants)IBA 04/2021
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2021
1	AllergensIBA 01/2021
1	TetracyclinesIBA 01/2021
1	Immunomodulating AgentsIBA 01/2021
1	Enoxaparin (Lovenox)FDA LinkGeneric 01/2021
1	Ritonavir (Norvir)FDA Link 01/2021
1	Lopinavir FDA Link 01/2021
1	tetraiodothyroacetic acid (TA(4))IBA 01/2021
1	AerosolsIBA 12/2020
1	InterferonsIBA 12/2020
1	Methylprednisolone FDA LinkGeneric 10/2020
1	S 10 (S-10)IBA 10/2020
1	erdosteineIBA 01/2020
1	Tirofiban (Aggrastat)FDA Link 01/2020
1	MucinsIBA 11/2019
1	Indicators and Reagents (Reagents)IBA 07/2019
1	Adenosine Monophosphate (AMP)IBA 01/2019

Therapy/Procedure

26	Therapeutics 12/2022 - 05/2009
7	Continuous Positive Airway Pressure 01/2022 - 12/2019
5	Nebulizers and Vaporizers (Inhaler) 01/2017 - 02/2010
3	Noninvasive Ventilation 12/2021 - 01/2021
3	Artificial Respiration (Mechanical Ventilation) 01/2021 - 01/2019
2	Mechanical Ventilators (Ventilator) 10/2020 - 04/2020
2	Biological Therapy 07/2020 - 01/2019
1	Immunomodulation 12/2021
1	Drug Therapy (Chemotherapy) 01/2020